Clinical Trial Detail

NCT ID NCT02512926
Title Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phoenix Children's Hospital
Indications

leukemia

Therapies

Cyclophosphamide

Carfilzomib

Etoposide

Age Groups: adult child

No variant requirements are available.